ImmuCell Corp (NASDAQ:ICCC)
CAPS Rating:
A biotechnology company serving veterinarians and producers in the dairy and beef industries with products that improve animal health and productivity.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked ICCC yet. Tell us why you think ICCC will outperform or underperform the market.
RSS Headlines
Fool UK
